Longs Drug Stores Corporation Announces New $200 Million Share Repurchase Program

WALNUT CREEK, Calif., Nov. 13 Longs Drug StoresCorporation (NYSE: LDG) today announced that its Board of Directors hasauthorized the repurchase of up to $200 million of the Company's outstandingcommon stock during the period extending through February 2011. Therepurchases will be made in open market transactions or through negotiatedtransactions from time to time, depending upon market conditions and theavailability of funds.

The Company has repurchased approximately $125 million in common stockunder a separate repurchase program authorized by its Board of Directors inMay 2005. The average purchase price was $46.40 per share. Approximately$25 million remains under this authorization that expires in May 2008.

Longs Drug Stores had a total of approximately 37.6 million sharesoutstanding as of the third quarter ended October 25, 2007.

About the Company

Headquartered in Walnut Creek, California, Longs Drug Stores Corporation(NYSE: LDG) is one of the most recognized retail drug store chains on the WestCoast and in Hawaii. The Company operates more than 500 retail pharmacies andoffers a wide assortment of merchandise focusing on health, wellness, beautyand convenience. Longs also provides pharmacy benefit management services andMedicare beneficiary prescription drug plans through its wholly-ownedsubsidiary, RxAmerica, LLC. Additional information about Longs and itsservices is available at http://www.longs.com and more information aboutRxAmerica is available at http://www.rxamerica.com.

SOURCE Longs Drug Stores Corporation

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...